Global Montelukast Sodium Market Growth 2023-2029

Global Montelukast Sodium Market Growth 2023-2029

Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis.
LPI (LP Information)' newest research report, the “Montelukast Sodium Industry Forecast” looks at past sales and reviews total world Montelukast Sodium sales in 2022, providing a comprehensive analysis by region and market sector of projected Montelukast Sodium sales for 2023 through 2029. With Montelukast Sodium sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Montelukast Sodium industry.
This Insight Report provides a comprehensive analysis of the global Montelukast Sodium landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Montelukast Sodium portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Montelukast Sodium market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Montelukast Sodium and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Montelukast Sodium.
The global Montelukast Sodium market size is projected to grow from US$ 336.3 million in 2022 to US$ 815.4 million in 2029; it is expected to grow at a CAGR of 815.4 from 2023 to 2029.
The global montelukast sodium sale market was led by USA, India, Europe and China, where the USA and India are important sales market. At present, there are some manufacturers in every region and the major manufacturers’ activities of montelukast sodium are Morepen Laboratories, Mylan, TAPI, MSN Laboratories, Ultratech India, Aurobindo Pharma, etc. Morepen Laboratories is the globe sales leader, holding 22% sales share in global.
This report presents a comprehensive overview, market shares, and growth opportunities of Montelukast Sodium market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Montelukast Sodium Amorphous
Montelukast Sodium Crystalline
Segmentation by application
Tablets
Chewable Tablet
Oral Solution
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Morepen Laboratories
Mylan
TAPI
MSN Laboratories
Ultratech India
Aurobindo Pharma
Hetero Labs
Unimark Remedies
Jubilant Cadista
Aamorb Pharmaceuticals
Sudarshan Group
Ortin Laboratories
Vamsi Labs
Adley Group
Medopharm
Hengyuan Pharmaceutical
Arromax Pharmaceutical Technology
Lihe Wuhan New Chemical Materials
Shanghai Huachu Chemical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Montelukast Sodium market?
What factors are driving Montelukast Sodium market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Montelukast Sodium market opportunities vary by end market size?
How does Montelukast Sodium break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.